Aquestive Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

Company Overview - Aquestive Therapeutics, Inc. is a pharmaceutical company focused on advancing medicines to improve patients' lives through innovative science and delivery technologies [3] - The company operates as both a developer of proprietary products and a Contract Development and Manufacturing Organization (CDMO) for licensees, with headquarters in New Jersey and manufacturing facilities in Indiana [3] - Aquestive is the exclusive manufacturer of four commercialized products marketed by its licensees across six continents, utilizing proprietary technologies like PharmFilm® [3] Upcoming Events - The management team will participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, 2026, with a presentation scheduled for February 26 at 12 pm ET [1][2] - A webcast of the presentation will be available on the company's website, with a replay accessible for 30 days following the event [2] Product Development - The company is advancing its AdrenaVerse™ platform, which includes a library of over 20 epinephrine prodrugs aimed at various allergy and dermatological indications [3] - Current product developments include Anaphylm™ (dibutepinephrine) sublingual film for severe allergic reactions, including anaphylaxis, and AQST-108 (epinephrine prodrug) topical gel for dermatological conditions like alopecia areata [3]